Loading organizations...
§ Private Profile · San Francisco, CA, USA
AI-powered EHR for independent mental health professionals
Orchid is an AI-powered Electronic Health Record (EHR) for independent mental health professionals that saves them time, money, and frustration by integrating core administrative workflows, streamlining clinical processes, and automating manual flows.
Orchid has raised $17.0M across 2 funding rounds.
Orchid has raised $17.0M in total across 2 funding rounds.
Orchid has raised $17.0M in total across 2 funding rounds.
Orchid's investors include Kevin Hartz, Alchemy Ventures, Andreessen Horowitz, Bessemer Venture Partners, Catalio Capital, CRV, Felicis Ventures, Founder Collective, Goat Capital, Greenoaks Capital, Haun Ventures, Infinite Niches.
Orchid has raised $17.0M across 2 funding rounds. Most recently, it raised $12.0M Seed in December 2023.
Orchid is an AI-powered electronic health record (EHR) platform specifically designed for independent mental health professionals such as therapists, psychiatrists, psychologists, and counselors. Its core product automates clinical note-taking and administrative tasks, enabling clinicians to spend more time on patient care and less on paperwork. Orchid’s AI can learn a clinician’s style, draft clinical notes, summarize medical histories, suggest billing codes and diagnoses, and generate after-visit summaries, all while maintaining HIPAA compliance. Thousands of clinicians already use Orchid, which integrates natively with its own EHR and can connect to other EHRs via a Chrome extension. By reducing administrative burdens, Orchid addresses clinician burnout and helps expand access to mental healthcare[1][2][3][4].
Orchid was founded by Joseph Pomianowski, a lawyer by training, who was motivated by the difficulty his friends faced in accessing mental healthcare due to clinicians being overbooked with administrative work. Recognizing that many mental health EHRs were outdated and inefficient, Pomianowski aimed to create a modern, AI-enabled platform to automate note-taking and other administrative tasks. The company gained early traction by collaborating with clinicians like psychiatrist David Halpern, who provided feedback on the product’s development. Orchid’s launch of its HIPAA-compliant AI clinical notes solution marked a pivotal moment, positioning it as the first AI-powered EHR tailored for mental health professionals[1][2][3].
Orchid rides the wave of AI adoption in healthcare, particularly the growing demand for solutions that reduce clinician burnout and improve operational efficiency. The mental health sector faces a clinician shortage and high administrative burdens, making AI automation timely and impactful. By focusing on independent mental health professionals—a large and underserved segment—Orchid addresses a critical bottleneck in mental healthcare access. Its HIPAA-compliant AI scribe technology exemplifies how AI can be safely integrated into sensitive healthcare workflows, influencing broader adoption of AI in behavioral health and beyond[1][2][3].
Orchid is poised to expand its user base by continuing to refine its AI capabilities and deepen integrations with other EHR platforms. As mental health demand grows and regulatory environments evolve, Orchid’s automation tools will become increasingly vital for clinician efficiency and patient access. Future trends likely to shape Orchid’s journey include enhanced AI personalization, expanded telehealth features, and broader ecosystem partnerships. Its influence may extend beyond mental health into other specialties requiring nuanced clinical documentation, reinforcing its role as a leader in AI-powered healthcare technology[1][2][3][4].